�����г���Ƶ

Adam J. Gordon's professional mission is to improve the access and quality of care of patients who have vulnerabilities, including those with addiction disorders. He is the Elbert F. and Marie Christensen Endowed Research Professor, tenured Professor of Medicine and Psychiatry at the �����г���Ƶ of Utah School of Medicine, and the Section Chief of Addiction Medicine at the VA Salt Lake City �����г���Ƶ Care System. He is a board-certified internal medicine and addiction medicine physician and is a Fellow in the American College of Physicians (FACP) and a Distinguished Fellow in the American Society of Addiction Medicine (DFASAM). He is the PI of the Greater Intermountain Node (GIN), a Center site of the NIH NIDA Clinical Trials Network; founded and is the Director of the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA); and founded and is the Emeritus Director the Vulnerable Veteran Innovative Patient-Aligned-Care-Team (VIP) Initiative, a clinical-evaluation initiative at the VA Salt Lake City �����г���Ƶ Care System. Adam J. Gordon is a Core Faculty member of the VA Salt Lake City Informatics, Decision-Enhancement and Analytic Sciences (IDEAS) Center, a Department of Veterans Affairs �����г���Ƶ �����г���Ƶ Research and Development (HSR&D) Center of Innovation (COIN). He is also the Editor-in-Chief of the journal Substance Abuse (impact factor 3.9).

Adam J. Gordon has a 25-year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations, including those who are homeless and those with substance use disorders. A major theme of his research includes examining the efficacy, effectiveness, and implementation of evidence-based identification, assessment, and treatments for patients with addiction. His methodological skills include health services, clinical trial, large database, and implementation science research. He has received efforts on over 100 federal peer reviewed grants from the NIH, VA, AHRQ, PCORI, and SAMHSA. He has authored over 310 peer reviewed articles (15.3% first authored, 27.2% senior authored, 40.8% authored with mentee) in high impact journals (e.g., JAMA, BMJ, Lancet; H-index=56) and presented/published hundreds of scholarly works. As evidence of how his research has impacted clinical care and my profession, he was awarded one of VA HSR&D’s highest honors by receipt of the 2021 VA �����г���Ƶ �����г���Ƶ Research and Development (HSR&D) “�����г���Ƶ System Impact Award” and received the 2022 David C. Lewis, MD Service to Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) Award.

He has mentored undergraduate, graduate, MD, and PhD trainees, VA and K- Career Development Awardees, and junior through tenured faculty. In addition, his post-doctoral mentees have received research Career Development Awards and have obtained large research awards. He is a primary or secondary mentor on over a dozen current or prior VA, NIH K-, or institutional K-awards. He has been honored locally and nationally for his mentorship abilities: named as an inaugural VA �����г���Ƶ �����г���Ƶ Research and Development National Mentor Network (MNet) mentor, received the “Allen Humphrey Excellence in Medical Student Research Mentoring Award” from the �����г���Ƶ of Pittsburgh School of Medicine, and was the recipient of the 2013 W. Anderson Spickard, Jr. Excellence in Mentorship Award from Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA). His time allocation (for a 60-hour work week between the �����г���Ƶ and the VA is 80% research/mentoring, 10% clinical/education, 10% administration).